Clinical guidelines for the use of dual-energy x-ray absorptiometry: a literature review (part I)
Open Access
- 30 June 2026
- journal article
- Published by Institute for Medical Radiology and Oncology of NAMS of Ukraine in Український радіологічний та онкологічний журнал
- Vol. 34 (2) , 269-289
Abstract
Background. Osteoporosis is a global health problem. Today, more than 200 million people worldwide suffer from this disease, and almost 9 million have osteoporotic fractures. Due to the demographic aging of the population, it is predicted that by 2040 the number of people at high risk of fractures will double. The economic burden is also enormous. In Europe alone, the costs associated with fragility fractures reached 37.5 billion euros in 2017, and this amount is projected to increase by another 27% by 2030. The high mortality rate (from 14% to 58%) in the first year after a hip fracture due to osteoporosis and the absolute invisibility and painlessness of pathological changes allow us to call the disease a «silent killer» that can be prevented through the timely use of dual-energy X-ray absorptiometry (DXA).Purpose – to review the latest published guidelines for the use of dual-energy X-ray absorptiometry in clinical practice.Materials and Methods. An analysis of full-text publications selected through a literature search in foreign (PubMed, Scopus, Lancet, ScienceDirect-Elsevier) and domestic databases for the period 2019 – 2025 was conducted.Results. An analytical review of the literature analyzed the experience of using dual-energy X-ray absorptiometry abroad, the technical aspects of the DXA procedure, approaches to interpretation and integration into clinical practice, as well as the use of bone mineral density (BMD) measurements.Conclusions. Dual-energy X-ray absorptiometry plays a key role in the diagnosis of osteoporosis, the assessment of fracture risk, and the monitoring of changes in bone mineral density. The advantages of DXA include its wide availability, ease of performance, and very low radiation dose. The clinical value of DXA depends largely on the quality of the scan, analysis, and interpretation of the results. Healthcare professionals are best placed to treat patients when BMD measurements are performed accurately and reliably and their interpretation meets established standards. Awareness of these quality standards can reduce diagnostic delays and facilitate multidisciplinary expert care.Keywords
This publication has 48 references indexed in Scilit:
- Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International WorkshopJournal of Bone and Mineral Research, 2020
- Vertebral Fractures and Morphometric DeformitiesJournal of Bone and Mineral Research, 2018
- Screening for Atypical Femur Fractures Using Extended Femur Scans by DXAJournal of Bone and Mineral Research, 2017
- Clinical height measurements are unreliable: a call for improvementOsteoporosis International, 2016
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral ResearchJournal of Bone and Mineral Research, 2013
- Osteoporosis in young adults: pathophysiology, diagnosis, and managementOsteoporosis International, 2012
- A systematic review of hip fracture incidence and probability of fracture worldwideOsteoporosis International, 2012
- Bone Densitometry in Clinical Practice2010
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO reportOsteoporosis International, 1994
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993